Skip to content

Paravertebral block by proxy and local anesthetic concentrations

Changes in Plasma Local Anesthetic Concentration at Different Drug Injection Sites in Paravertebral block by proxy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1031240233
Enrollment
40
Registered
2024-07-24
Start date
2024-08-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spontaneous pneumothorax, patients undergoing lobectomy for lung tumours

Interventions

Two types of paravertebral proximal blocks are performed and blood local anaesthetic concentrations are measured at defined times after local anaesthetic injection. The maximum plasma concentration of

Sponsors

Nakazawa Keisuke
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Adults 20 years of age or older 2) Those who fall under BMI 18.5 to 25.0 kg/m2 3) Patients with American Society of Anesthesiologists Pre-Anesthesia Risk Assessment (ASA-PS) 3 or less (ASA-PS Classification 1: No organic, biochemical or psychiatric abnormalities. Classification 2: Mild to moderate systematic impairment. Classification 3: Severe systematic disorder. Classification 4: Severe, life-threatening systemic disorders that cannot be cured by surgery (Classification 5: Dying). Classification 5: Dying.) 4) Persons who give written consent to participate in the research.

Exclusion criteria

Exclusion criteria: 1) Patients who do not meet the above selection criteria 2) Patients allergic to amide-type local anesthetics 3) Patients on anticoagulation therapy with PT-INR (Prothrombin Time International Normalized Ratio) > 1.2 or on dual anti-platelet therapy (DAPT), excluding biaaspirin monotherapy and prophylactic low molecular weight heparin therapy 4) Patients with any of the contraindications listed in the package insert. 5) Patients with moderate to severe hepatic dysfunction 6) Patients with arrhythmia requiring pacemaker insertion 7) Patients who meet all of the above selection criteria and none of the above exclusion criteria. 8) Patients who have refused to participate in this study.

Design outcomes

Primary

MeasureTime frame
Determine the maximum local anaesthetic plasma concentration C max and the time Tmax (min) to reach the maximum plasma concentration from the value of the ropivacaine plasma concentration at 5min, 10min, 15min, 30min, 45min, 60min, 90min and 120 min after nerve block.

Secondary

MeasureTime frame
Patient pain score VAS or NRS after extubation in the operating theatre (0 h, 2 h, 6 h, before sleep, next morning after surgery, 24 h after extubation), record of analgesic use, presence of PONV, vital signs on leaving the operating theatre (max/min/average blood pressure, respiratory rate, pulse rate), other, patient information and treatment from the electronic anaesthetic record Information and treatment details, number of cases requiring additional prescriptions for rescue analgesia (NSAIDs, weak opioid analgesics) in the intensive care unit and the time since awake extubation when that additional analgesia was requested.

Contacts

Public ContactKeisuke Nakazawa

Nihon University School of Medicine Itabashi Hospital

nakazawa.keisuke@nihon-u.ac.jp+81-3-3972-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026